ArticleBMC cancer2025

The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.

Shaohua Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.